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Protein phosphorylation is a ubiquitous mecha-
nism for cellular signal propagation, and signal-
ing network complexity presents a challenge to
protein kinase substrate identification. Few
targets of Polo-like kinases are known, despite
their significant role in coordinating cell-cycle
progression. Here, we combine chemical-ge-
netic, bioinformatic, and proteomic tools for
Polo-like kinase substrate identification. Spe-
cific pharmacological inhibition of budding
yeast Polo-like kinase, Cdc5, resulted in a mis-
aligned preanaphase spindle and subsequently
delayed anaphase nuclear migration, revealing
a Cdc5 function. A cellular screen for Cdc5 sub-
strates identified Spc72, a spindle pole body
(SPB) component and microtubule anchor re-
quired for nuclear positioning. Spc72 bound to
the Cdc5 PBD in a mitosis-specific manner,
was phosphorylated by Cdc5 in vitro, and dem-
onstrated a loss of mitotic phosphorylation in
vivo upon Cdc5 inhibition. Finally, an examina-
tion of Cdc5 binding by SPB-localized proteins
expanded our knowledge of Cdc5 function at
the SPB.
INTRODUCTION
Ensuring accurate chromosome segregation is funda-
mental to survival of a species. Temporally and spatially
regulated signals are required to monitor and direct multi-
ple cellular events during cell division. The Polo-like family
of serine/threonine protein kinases (Plks) has emerged as
an important class of cell-cycle regulators that coordinate
mitotic progression, with multiple roles from mitotic entry
to cytokinesis [1]. Humans have four Plks (Plk1-4), of
which Plk1 is most thoroughly characterized [1]. The bud-
ding yeast S. cerevisiae has a single Plk, Cdc5, with 49%Chemistry & Biology 14, 1261–1272identity to Plk1 in its kinase domain [2]. Cdc5 regulates
multiple cellular functions, including progression through
G2/M phase, cohesin cleavage at anaphase entry, and
adaptation to the DNA damage checkpoint. Cdc5 also
has an essential role in promoting mitotic exit and cytoki-
nesis as part of two signaling networks called FEAR and
MEN [2].
Despite themultiplemitotic functions ofCdc5, only a few
of its substrates have been conclusively identified [3–6].
Cdc5 substrates are difficult to identify for several reasons.
First, cell-cycle regulators are generally low abundance
proteins, and both Cdc5 and its known substrates are
present at less than1,500 copiesper cell [7]. Second, char-
acterized phosphorylation sites in Plk substrates have
considerable sequence variation [8] and are of limited
utility in identifying potential substrates. Third, Cdc5 is
a particularly promiscuous kinase when used in in vitro re-
actions. Fourth, different cdc5-ts (temperature-sensitive)
alleles have given rise to differing terminal phenotypes
making the study of Cdc5 function in vivo complex [4].
The variation in phosphorylation site preference of Cdc5
suggests that alternative specificity determinants exist,
such as temporal and spatial regulation. Indeed, Cdc5
levels are tightly regulated with maximal activity in mitosis,
due to both cell-cycle coordination of transcription and
APC-mediated proteolysis [2]. Also, Cdc5 has a distinct
localization pattern including the cytoplasmic face of the
spindle pole body (SPB, the functional equivalent to the
mammalian centrosome), chromosomes, and the bud
neck (the future site of cytokinesis) [5, 9–11]. This localiza-
tion is driven by a C-terminal region of Plks, called the
Polo-box domain (PBD), asmutations in it severely disrupt
the Cdc5 localization pattern [10]. The PBD is a phospho-
serine/threonine binding module that targets Plks to their
substrates after prior ‘‘priming’’ phosphorylation of the
substrate by an upstream kinase [8, 12].
The importance of cellular localization for Cdc5 sub-
strate specificity motivated us to develop an in vivo screen
for identifying bona fide Cdc5 substrates. To accomplish
this, we generated a specific Cdc5 inhibitor by using
a chemical-genetic approach, which allowed for the se-
lective and temporal inhibition of Cdc5 in cells. Using, November 2007 ª2007 Elsevier Ltd All rights reserved 1261
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Polo-like Kinase Targets Spc72 in MitosisFigure 1. Analog-Sensitive Cdc5 Is In-
hibited by CMK
(A) Sequence alignment of kinase domain re-
gions spanning the gatekeeper residue and
the reactive cysteine. The Cdc5 sequence is in
bold, and the specificity filters critical for RSK2
inhibition by CMK [22] are highlighted in gray.
(B) Chemical structure of CMK. CMK (in gray),
with features of the kinase active site depicted,
including a cysteine to react with the electro-
philic chloromethyl ketone and a gatekeeper
residue that controls access to a hydrophobic
binding pocket. A predicted steric clash be-
tween the Cdc5 leucine gatekeeper residue
and CMK is illustrated.
(C) Cell viability halo assay of wild-type (CDC5)
and cdc5-as1 yeast. Inhibition of cell growth in
the region surrounding a disc spotted with
1 nmol CMK or scaffold molecule is observed
only upon CMK application to cdc5-as1 (cen-
ter), indicating a requirement for both the gate-
keeper mutation and the electrophilic reactivity
of CMK.this inhibitor, we found a novel role for Cdc5 in preana-
phase spindle orientation and anaphase spindle
migration. Candidate Cdc5 substrates were identified by
bioinformatic filtering of the proteome by using Cdc5
phosphorylation and PBD binding site preferences, as
well as functional criteria. The candidates were screened
by chemical inhibition of Cdc5 in vivo. This approach iden-
tified novel Cdc5 substrates, including the SPB compo-
nent Spc72. The SPB projects cytoplasmic microtubules
required for positioning of the nucleus, orientation of the
mitotic spindle, and subsequent movement of one set of
chromosomes across the predetermined cleavage plane
at the bud neck [13]. Spc72 anchors cytoplasmic microtu-
bules at the SPB and accordingly functions in nuclear
position and spindle orientation, including anaphase spin-
dle migration into the bud [14–17]. We demonstrate that
Spc72 (along with other SPB components) binds to the
Cdc5 PBD. Thus, Cdc5 has a previously unidentified func-
tion at the SPB and in spindle positioning.
RESULTS
CMK Selectively Inhibits an Analog-Sensitive
Allele of Cdc5
To evaluate cellular roles of budding yeast Cdc5, we
engineered Cdc5 to be selectively inhibited by a cell-
permeable small molecule by using a chemical-genetic
approach. This method involves introducing a space-cre-
ating mutation at the gatekeeper position coupled with
a space-filling bulky derivative of the pyrazolopyrimidine
(PP1) kinase inhibitor scaffold [18]. We previously found
the cdc5-as1 allele (analog-sensitive) encoding the L158G
gatekeeper mutation to poorly complement a cdc5-ts
strain at restrictive (37C) temperature [19]. However,
Cdc5(L158G) had only a modest 6-fold reduction in
kcat/Km [20], and when CDC5 was replaced at its
endogenous locuswith the cdc5-as1 allele, cdc5-as1 cells1262 Chemistry & Biology 14, 1261–1272, November 2007 ª20were viable with a 47% increase in strain doubling time at
30C, indicating that Cdc5(L158G) is a functional kinase
in the context of this study (data not shown). Since func-
tional Cdc5 is required for cellular proliferation, we used
growth inhibition to assess Cdc5 inactivation. Surpris-
ingly, we were unable to obtain significant inhibition of
Cdc5(L158G) with a variety of PP1 analogs despite the
diverse collection of other protein kinases that have
proven amenable to this approach [21] (data not shown).
Thus, the ATP binding site of Cdc5 differs enough from
other kinases that a new inhibitor strategy was necessary.
Fortunately, the Cdc5 active site contains a noncon-
served cysteine (Cys96) homologous to a cysteine in the
mammalian p90 RSK family kinases that was recently
exploited for the rational design of selective, irreversible
inhibitors (Figure 1A). These inhibitors are pyrrolopyrimi-
dines containing either a chloromethylketone (CMK) or
a fluoromethylketone (FMK) electrophile at the C-2 posi-
tion, and like PP1, exploit a threonine (or smaller) gate-
keeper residue [22]. We therefore hypothesized that these
irreversible inhibitors would inactivate Cdc5(L158G) by
virtue of the absence of a bulky gatekeeper residue and
the presence of a naturally occurring Cys at position 96
(Figure 1B). Growth of the cdc5-as1 strain, but not the
wild-type strain (CDC5), was prevented by treatment
with CMK, but not its parent pyrrolopyrimidine (scaffold),
which does not contain the chloromethyl ketone electro-
phile (Figure 1C). Similarly, the in vitro IC50 of CMK for
Cdc5(L158G) was 36 nM, compared with greater than
30 mM for wild-type Cdc5 (Figure S2, see the Supplemen-
tal Data available with this article online). Additionally,
CMK did not inhibit growth of yeast containing a Cdc5
allele with both L158G and C96V mutations (Figure S1A).
This suggests that inactivation of Cdc5(L158G) with
CMK is mediated by irreversible covalent bond formation
with Cys96. Notably, although a threonine gatekeeper res-
idue is sufficient for inhibition of RSK by CMK [22], Cdc507 Elsevier Ltd All rights reserved
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Together, the cdc5-as1 strain and CMK provide a means
to study cellular roles of Cdc5.
Cdc5 Is Required for Proper Spindle Orientation
and Migration
We sought to determine the nature of the growth arrest
caused by CMK addition to cdc5-as1 yeast. Wild-type
and cdc5-as1 strains were released from a G1 arrest (un-
budded cells) into media containing increasing concentra-
tions of CMK, and cell-cycle progression was determined
by microscopic observation of budding (Figure 2A). CMK
exhibited a concentration-dependent first cell-cycle mi-
totic arrest in the cdc5-as1 strain with an IC50 of 1.1 mM
(Figure 2B). By contrast, up to 15 mM CMK had no effect
on cell-cycle progression in the wild-type strain (Fig-
ure 2A). We examined in precise detail the arrest pheno-
type at 5 mM. Notably, arrested cells were large-budded
with separated DNA masses and elongated spindles.
Pds1 degradation occurred with similar kinetics in both
strains, indicating that anaphase onset in budding yeast
is unaffected by Cdc5 inhibition (Figure 2C). Strikingly,
we also observed a high percentage of anaphase cdc5-
as1 cells (23%) in which spindle elongation occurred en-
tirely in the mother cell, rather than through the bud neck
(Figures 2E and 2F). This was a rare event in anaphase
wild-type cells (2%) and implies a failure of the nucleus
to migrate into the bud upon anaphase onset. Expression
of wild-typeCdc5 in the cdc5-as1 cells rescued this defect
(4% anaphase spindles in mother), while expression of
Cdc5 containing a defective Polo-box domain could not
(17% anaphase spindles in mother). Inhibited cdc5-as1
cells were able to elongate their spindles to greater than
5 mm without spindle migration into the bud (Figure 2F).
The spindles eventually recovered from this defect, and
the cells later arrested in telophase with high Clb2 levels
(Figure 2C) and DNA masses segregated properly into
mother and daughter (Figure 2D).
To further clarify the phenotype resulting from
Cdc5(L158G) inhibition, we introduced cdc5-as1 into cells
in which a centromere-proximal chromosomal array is
bound by GFP [23], thus allowing visualization of sister
chromatid separation. Consistent with the previously de-
scribed role for Cdc5 in promoting Scc1 cleavage [24],
we observed a slight delay in the separation of centro-
meres in CMK-treated cdc5-as1 cells, as monitored by
the separation of centromere-proximal GFP arrays, and
a protracted delay in the complete separation of DAPI-
stained DNAmasses, relative to CMK-treatedCDC5 yeast
(Figure 2G). Furthermore, a thorough analysis of the mi-
totic spindle with time revealed that short, preanaphase
spindles were frequently misaligned in CMK-treated
cdc5-as1 cells (55% of preanaphase spindles in CMK-
treated cdc5-as1 versus 19% in CMK-treated CDC5 at
75 min) (Figure 2H). The preanaphase nucleus was cor-
rectly positioned at the bud neck (Figure 2I and data not
shown), indicating that cytoplasmic microtubule guidance
was intact. Whereas in cells with properly aligned preana-
phase spindles, only the bud-proximal SPB directs cyto-Chemistry & Biology 14, 1261–1272plasmic microtubules into the bud, in cells with misaligned
preanaphase spindles, cytoplasmic microtubules from
both poles were directed into the budneck (Figure 2I).
This implies that Cdc5 activity is required to prevent
a daughter-directed force guiding cytoplasmic microtu-
bules emanating from themother bound SPB, as an active
mother-directed force is not thought to exist prior to ana-
phase. As shown in Figure 2J, we also observed a small
number of CMK-treated cdc5-as1 cells with detached
cytoplasmic microtubules, which were not observed in
CMK-treated CDC5 cells. Clearly, chemical Cdc5(L158G)
inhibition results in pluripotent defects in cell-cycle pro-
gression, including both previously described Cdc5 func-
tions (sister chromatid separation and late anaphase
progression), and a newly described Cdc5 function in
properly positioning the mitotic spindle.
Cdc5 Substrates Are Identified through
a Candidate-Based In Vivo Screen
A role for Cdc5 in spindle positioning was not previously
known and cannot be easily explained by its previously
identified substrates. Proper anaphase spindle migration
required both Cdc5 catalytic activity and Polo-box domain
function, suggesting that the critical substrates would
likely contain sequences recognized by both the Polo-
box domain and kinase domain (Figure 3A). Therefore,
a candidate approach to identifying substrates was
designed to incorporate both of these elements (Fig-
ure 3B).
Briefly, the roughly 6,000 predicted yeast proteins were
searched with the Scansite profile scanning algorithm [25,
26] for Cdc5 binding and phosphorylation sequence
motifs, generating a ‘‘Cdc5 substrate likelihood score’’
for each protein. The Cdc5 binding motif was determined
previously by oriented library screening [27]. A predicted
Cdc5 phosphorylation motif was generated by combining
information on Cdc5, Plk1, and Plk3 substrates [8] with the
published kinase phosphorylation motif of Plk1 [8, 28]
since both Plk1 and Plk3 can substitute for Cdc5 function
in yeast [2]. The distribution of scores is represented in
Figure 3C, with high scores representing likely substrates.
Notably, the group of best-scoring potential Cdc5 sub-
strates was enriched in low abundance proteins relative
to the entire proteome, requiring a sensitive test of candi-
date phosphorylation (Figure 3D). Cdc5 substrate likeli-
hood scores combined with functional criteria led us to
choose 192 total candidate substrates (Table S1). Among
the proteins identified by this approach were the known
Cdc5 substrates Mcd1, Bfa1, and Swe1 [4, 5, 24]. Swe1
is the only of the three previously shown to directly
bind the PBD [29] and was ranked 12th highest overall
(Table S1).
To test these candidate substrates for Cdc5-dependent
phosphorylation in vivo, we used a library of strains each
encoding a candidate substrate, at its endogenous locus,
fused to a tandem affinity purification (TAP) tag, which
provided an ultra-sensitive handle for immunological de-
tection [7]. The phosphorylation state of the TAP-tagged
candidates was monitored by gel shift, a straightforward, November 2007 ª2007 Elsevier Ltd All rights reserved 1263
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Polo-like Kinase Targets Spc72 in MitosisFigure 2. CMK Inhibition of Cdc5(L158G) Leads to a First Cell-Cycle Anaphase Arrest and Delay in Anaphase Spindle Migration
(A) CMK treatment causes a first cell-cycle arrest of cdc5-as1, but not wild-type, cells in a dose-dependent manner. Time course of cell-cycle-
synchronizedCDC5 and cdc5-as1 cultures released fromG1 arrest (unbudded) into the indicated concentrations of CMK (n = 200 cells for each point)
is plotted. The y axis represents the percentage of cells in S/G2 andM phases, as judged by the presence of a medium- to large-sized bud. A second
cell cycle was prevented by rearrest in the subsequent G1.
(B) cdc5-as1 cells arrest with an extracellular 50% inhibitory CMK concentration of 1.1 mM (dotted line, 95% confidence interval from 0.9 to 1.2 mM).
The percent cdc5-as1 cells in S/G2 and M cell-cycle phases at 180 min is shown for CMK-treated cultures prepared as in (A). Error bars represent
standard errors of the mean for three experiments (n = 200 cells for each), and the data were fit to a sigmoidal dose response curve (R2 = 0.97).1264 Chemistry & Biology 14, 1261–1272, November 2007 ª2007 Elsevier Ltd All rights reserved
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phorylation state of many proteins in vivo [30]. We
focused on the candidates that exhibited a gel shift in a
mitotic arrest, when Cdc5 is active, but not in a G1 arrest,
when Cdc5 is inactive [31] (Figure 3B). Mitotically arrested
cells were treated for 20 min with 10 mM CMK or DMSO
(control). To avoid false-positive phosphorylation, cdc5-
as1 was the sole source of Cdc5, and CMK was added
for only 20 min to limit indirect effects of Cdc5 inhibition.
Of the 74 proteins that displayed a gel mobility shift
when isolated from mitotic cells, five exhibited reproduc-
ible Cdc5-dependent changes in gel mobility (Figure 3E
and Table S1). Significantly, of the three known Cdc5 sub-
strates included in our screen, Bfa1 and Mcd1 [4, 24]
downshifted upon Cdc5 inhibition. Similarly, Spc72 and
Ulp2 also downshifted upon Cdc5 inhibition. Spc72 is
a previously described phosphoprotein, but the upstream
kinase had not been identified [32]. Intriguingly, Cdc5 inhi-
bition resulted in an upshift of Mih1. The chemical nature
of this shift is unclear, since it is unusual for loss of phos-
phorylation to result is a slower migrating form.
The SPB Component Spc72 Is a Cdc5 Substrate
and Binding Partner in Mitosis
Spc72 has several hallmarks of a Cdc5 substrate impor-
tant for the regulation of spindle positioning. It contains
both Cdc5 PBD-binding and phosphorylation motifs, ex-
hibits Cdc5-dependent phosphorylation, and is a SPB
component with a previously known function in nuclear
positioning [14–17]. Spc72 phosphorylation was exam-
ined through the cell cycle to further explore this connec-
tion. In wild-type cells, Spc72 phosphorylation peaked
in late mitosis, just as Clb2 levels begin to decrease
(Figure 3F). This Spc72 mobility shift was prevented
when Cdc5 was inhibited by treating cdc5-as1 cells with
CMK (Figure 3F). Finally, purified 6xHis-tagged Cdc5
directly phosphorylated immunoprecipitated TAP-tagged
Spc72 in vitro (Figure 3G), suggesting that Spc72 is a di-
rect substrate of Cdc5.Chemistry & Biology 14, 1261–127Spc72 was previously reported to bind to Cdc5 [33, 34],
and we investigated the nature of this interaction. To de-
termine whether binding could be mediated by phos-
pho-dependent interactions between Spc72 and the
Cdc5 Polo-box domain, we performed pull-down experi-
ments for Spc72 in mitotic extracts with either the PBD re-
gion of wild-type Cdc5 or a PBD variant (PBD*) in whichwe
introduced mutations corresponding to conserved resi-
dues in Plk1 required for phospho-specific binding [27]
(Figure 4A). Spc72 efficiently bound to the PBD, relative
to a 5% input control, but failed to bind to PBD*, indicating
that prior Spc72 phosphorylation by a priming kinase cre-
ates a Cdc5 binding site (Figure 4B). Consistent with this,
the interaction was also regulated by cell-cycle stage
since Spc72 bound the PBD less well in a G1 extract
than in a mitotic extract (Figure 4C). Spc72 contains sev-
eral minimal PBD binding sites and a site at S232 with
the 74th best Scansite score out of 6,833 matches to the
PBD binding site in the yeast proteome. Mutation of
S231 and S232 at this site significantly reduced binding
to the PBD (Figure 4E), suggesting that Spc72 and Cdc5
bind directly. Residual binding to this Spc72 mutant may
reflect contributions from other sites in Spc72 or Cdc5
PBD interactions with Spc72 binding partners.
To identify other mediators of Cdc5 binding at the SPB,
we tested the ability of the Cdc5 PBD to bind 90 proteins
that were either annotated as SPB-localized or identified
as SPB-localized in a proteomic study [35]. Notably,
PBD binders at the SPB may include Cdc5 substrates in-
volved in anaphase spindle migration since the PBD is re-
quired for both Cdc5 localization to the SPB [10] and
proper anaphase spindle migration. SPB-localized pro-
teins were examined for PBD binding in extracts of mitot-
ically arrested cells (Table S2). Components of the SPB
cytoplasmic face, Spc72, Cnm67, and Nud1, bound to
the PBD, as did known Spc72-binding proteins, Spc97,
Stu2, and Kar1 (Table S2). Themost efficient PBD binders,
determined by the ratio of input and PBD-bound protein
levels, are shown in Figure 4F. These included mitotic
exit signaling network components, Cdc14 and Bub2,(C) CMK-treated cdc5-as1 cells degrade Pds1 with wild-type kinetics but maintain stabilized Clb2. Cell extracts from CDC5 and cdc5-as1 strains
expressing Pds1-HA3 released from G1 into 5 mM CMK and rearrested in the subsequent G1 were blotted for HA (Pds1) and Clb2.
(D) CMK-treated cdc5-as1 cells arrest as budded cells with segregated chromosomes. Budded cells (squares) and budded cells with DNA masses
separated into mother cell and bud (circles) were quantified in CMK-treated CDC5 (closed symbols) and cdc5-as1 (open symbols) strains for the ex-
periment shown in (C) (n = 100 cells per point).
(E) Mother cell localized anaphase spindles are transiently observed in CMK-treated cdc5-as1 cells. The percentage anaphase spindles with local-
ization depicted (n = 100 cells) in CMK-treated cdc5-as1 and CDC5 cells at 105 min in the experiment shown in (C and D).
(F) Examples of CMK-treated cells with anaphase spindles (tubulin) observed at 90 min in the experiment shown in (C through E). The images show
aberrant (cdc5-as1) and wild-type (CDC5) anaphase spindle localization, but are not representative of all cells in the population. The scale bar rep-
resents 5 mm.
(G) CMK-treated cdc5-as1 cells have a delay in completing chromosome separation. CDC5 (black) and cdc5-as1 (gray) strains expressing tetR-GFP
and containing a centromere-proximal tetO array, released from G1 into 5 mMCMK and rearrested in the subsequent G1, were analyzed for budding
(squares), separation of fluorescent GFP chromosomal dots (diamonds), and separation of DNA masses (circles) (n = 100 cells per point).
(H) CMK-treated cdc5-as1 cells have misaligned preanaphase spindles. Cells with an anaphase spindle (squares), with a preanaphase short spindle
(diamonds), and with a misaligned preanaphase spindle (circles) in CMK-treated CDC5 (black) and cdc5-as1 (gray) strains were quantified for the
experiment shown in (G) (n = 100 cells per point).
(I) Examples of cells with preanaphase spindles (tubulin) observed in the experiment shown in (G)–(H). The images show misaligned and normal pre-
anaphase spindles, which are quantified in (H).
(J) Detached cytoplasmic microtubules observed in a small number of CMK-treated cdc5-as1 cells. Examples of tubulin-stained cells observed in the
experiment shown in (G) through (I) with detachedmicrotubules indicated (arrows). The images represent only a small number of cells in the cdc5-as1
population. No detached microtubules were observed in CMK-treated CDC5 cells.2, November 2007 ª2007 Elsevier Ltd All rights reserved 1265
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Polo-like Kinase Targets Spc72 in MitosisFigure 3. A Candidate-Based In Vivo Screen Identifies Spc72 as a Cdc5 Substrate
(A) Schematic representation of substrate recognition by Cdc5. The substrate is depicted to contain a Cdc5 phosphorylationmotif, (D/E/N)X(S/T) [58],
and a binding motif, S(pS/pT)(P/X), which binds the Cdc5 Polo-boxes (PB1 and PB2) [27]. X represents any amino acid, p represents phosphorylation.
(B) Approach to screening for substrates phosphorylated by Cdc5 in vivo.
(C) Bioinformatic mining of the yeast proteome for candidate Cdc5 substrates. The distribution of assigned Cdc5 substrate likelihood scores is shown
for 192 Cdc5 candidate substrates compared with the proteome, with low scores reflecting likely candidates.1266 Chemistry & Biology 14, 1261–1272, November 2007 ª2007 Elsevier Ltd All rights reserved
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Polo-like Kinase Targets Spc72 in Mitosiskinetochore proteins, Cse4 and Tid3, and the SPB com-
ponent, Spc110 (Figure 4F). Significantly, Spc72 was
among the most efficient binders, implying both that it
directly interacts with the PBD and is a major site of
Cdc5 binding at the SPB (Figure 4F).
DISCUSSION
Here, we report a chemical-genetic and bioinformatic
approach to investigate the cellular roles of the yeast
Plk, Cdc5. Specific chemical inhibition of Cdc5 by CMK
both revealed a new role for Cdc5 in mitotic spindle posi-
tioning and facilitated identification of Spc72 as a Cdc5
substrate. Analysis of Spc72 regulation supports a model
in which a kinase primes Spc72 for binding to Cdc5 at the
SPB in mitosis, resulting in direct Spc72 phosphorylation
by Cdc5. Interestingly, the phenotype resulting from loss
of Spc72, althoughmore severe than fromCdc5 inhibition,
is consistent with Spc72 being a Cdc5 effector in spindle
positioning [14–17].
Chemical-genetic engineering of Cdc5 posed a signifi-
cant challenge, as Cdc5 was unexpectedly incompatible
with our previously extensively validated approach. Unlike
other engineered kinases, including Plk1 [36], Cdc5 was
not inhibited by nonelectrophilic PP1 analogs. Although
a Plk1 kinase domain structure was recently published
[37], no Cdc5 structure is available. Our results indicate
that access to the hydrophobic pocket in Cdc5 is reduced
relative to other protein kinases that we have studied. Sim-
ilar to RSKs, Plks have a nonconserved active site cyste-
ine, which provided a handle for potent irreversible Cdc5
inhibition. Although Cdc5 is the only budding yeast Plk,
since the cysteine is conserved across the family, the
chemical-genetic inhibition strategy should be applicable
to studying any Plk family member. Several potent Plk in-
hibitors have recently been described, and although some
exhibit selectivity for Plk family kinases, they do not dis-
criminate between the closely related mammalian Plk
isoforms [38–43]. Chemical-genetic methods present a
unique pharmacological capability to study the function
of a single Plk isoform in the presence of other active fam-
ily members [36]. One extension of the strategy described
here could be in studying mammalian Plk isoforms when
irreversible kinase inhibition is preferable, such as for
active site labeling [44].
Small-molecule addition rapidly inhibits only the cata-
lytic activity of the kinase, both avoiding compensatory
mechanisms occurring in the absence of the kinase andChemistry & Biology 14, 1261–1272allowing for study of temporally resolved processes, and
has often revealed new aspects of kinase function missed
by genetic approaches [45]. In addition to delaying chro-
mosome segregation and blockingmitotic exit and cytoki-
nesis, inhibition of Cdc5(L158G) by CMK resulted in aber-
rant preanaphase spindle orientation, followed by a delay
in anaphase spindle migration into the bud. The defect
was corrected eventually, and the spindle moved into
the neck, either due to redundant activities or by forces
generated by the elongating spindle itself. Since cytoplas-
mic microtubules from both poles of misaligned preana-
phase spindles were bud directed, Cdc5 activity is likely
required to prevent a preanaphase daughter-directed
pulling force. Interestingly, other components of the
FEAR pathway act during anaphase to either prevent
a daughter-directed force or activate a mother-directed
force, a similar but temporally and phenotypically distinct
function from Cdc5 [46]. Our chemical-genetic approach
to Cdc5 inhibition provides a tool to probe the molecular
mechanisms coordinating spindle position with the cell
cycle. In yeast, movement of the anaphase spindle into
the bud is required for proper chromosome segregation
due to a predetermined cleavage plane. In higher organ-
isms, spindle position is critical for developmental cell-
fate decisions [13]. Previous studies with cdc5-ts alleles
revealed only the essential Cdc5 functions, as they are
more conducive to endpoint assays. Also, elevated tem-
peratures required for inactivating ts alleles accelerate
the cell cycle, potentially masking transient effects such
as a role in spindle positioning. Thus, this novel Cdc5 func-
tion was revealed only by the pharmocologic modulation
of Cdc5 activity.
Our substrate screen combined several recent techno-
logical advances to meet the stringent requirement of low
abundance Cdc5 substrate identification in vivo. Identifi-
cation of direct Cdc5 targets necessitated selective and
rapid Cdc5 inactivation for a brief period, and chemical
genetics ideally suited this purpose. Unlike mass spec-
trometry approaches, which suffer from limited dynamic
range [7], utilization of the TAP-tag proteomic library facil-
itated the visualization of even low abundance phospho-
proteins by gel shift. Phosphorylation reactions occurred
only in a cellular context, and to avoid artifacts from over-
expression, both analog-sensitive Cdc5 and the candi-
dates were expressed from their endogenous loci. A can-
didate approach made this screen feasible, and while the
Cdc5 binding and phosphorylation motifs are degenerate,
a useful set of candidates was obtained by utilizing the(D) Cdc5 candidate substrates are enriched in low abundance proteins. Normalized distribution of protein abundance [7] comparing candidate Cdc5
substrates to the entire proteome. The data set meanswere statistically different (p = 0.0003) by unpaired t test. Proteins without abundance values [7]
were excluded from the analysis.
(E) Result of the screen. The gel mobility of five TAP-tagged candidate substrates is altered upon Cdc5 inhibition with 10 mM CMK (+) as compared
with a DMSO control treatment ().
(F) Inhibition of Cdc5 with CMK eliminates the mitotic Spc72 upshift observed in a synchronized cell cycle. Cell-cycle progression of CDC5 or cdc5-
as1 cells expressing Spc72-TAP released from G1 into 10 mMCMK is indicated by budding index and Clb2 western blot. Spc72 is visualized by anti-
TAP western blot (Spc72).
(G) In vitro phosphorylation of Spc72 byCdc5. Immunopurified TAP-tagged Spc72was incubatedwith [g-32P]ATP, with andwithout purified Cdc5 (left
panels). Phosphorylation (32P) and Spc72 western blot (a-TAP) are observed. No Spc72 phosphorylation is seen when Cdc5 is added to a mock pull-
down reaction containing untagged Spc72 (- Spc72-TAP) (right panels)., November 2007 ª2007 Elsevier Ltd All rights reserved 1267
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Polo-like Kinase Targets Spc72 in MitosisFigure 4. Spc72 Binds to the Cdc5 Polo-Box Domain in a Cell-Cycle and Phospho-Specific Manner
(A) Cdc5 domain structure indicating the kinase domain and Polo-box domain (PBD) and sequence alignment showing three conserved PBD residues
required for phosphopeptide binding by Plk1 (highlighted in gray). The PBD* mutant contains mutations of the highlighted Cdc5 residues to the amino
acids indicated for elimination of phospho-specific motif binding.
(B) Spc72 is bound by the Cdc5 PBD, and PBD* has reduced Spc72 binding. Anti-TAP (Spc72) western blot indicates Spc72 present in the input
mitotic cell extract (I) or pulled down (P) with GST-PBD (PBD) or GST-PBD* (PBD*). Total protein staining indicates the amount of GST-fusion protein
in pull-down lanes (P). I, 5% input; P, pull-down.
(C) Cdc5 preferentially binds mitotic Spc72. Wild-type PBD pull-downs from mitotic cell extracts (as in [B]) or G1 phase cell extracts were probed for
Spc72.
(D) Domain structure of Spc72 including coiled-coils predicted by COILS [59] and sites matching Cdc5 phosphorylation, (D/E/N)X(S/T) [58], and PBD
binding, S(S/T) [27], minimal motifs. The best scoring PBD binding motif in Spc72 is indicated (asterisk).1268 Chemistry & Biology 14, 1261–1272, November 2007 ª2007 Elsevier Ltd All rights reserved
Chemistry & Biology
Polo-like Kinase Targets Spc72 in Mitosisextra information contained in weighting amino acids at
each position based on their preference by Cdc5. Func-
tional criteria are a useful filter for substrate sets [47] and
were also incorporated into the selection process. How-
ever, we were limited by the proportion of phosphopro-
teins that demonstrated significant phosphorylation shifts.
Further advances in mass spectrometric approaches that
quantitatively detect differences in low stoichiometry
phosphopeptides in a complex mixture are necessary to
improve this approach [48].
Although the screen was not limited to these proteins,
we were interested in finding substrates consistent with
the Cdc5 spindle position phenotype, such as molecular
motors required to generate a bud-directed pulling force,
cortical determinants that interact with cytoplasmic micro-
tubulespenetrating into thebud,orproteins that stabilizeor
nucleate cytoplasmic microtubules [13]. Of the Cdc5 sub-
strates identified, only Spc72 has a known role in spindle
position, which is similar, but not identical, to Cdc5(L158G)
inhibition. Loss of Spc72 causes reduced cytoplasmic
microtubules, resulting in defects in cytoplasmic microtu-
bule-dependent processes, such as nuclear position and
spindle orientation, and a delay in mitotic exit due to
anaphase spindles that have not properly migrated into
the bud [14–17]. Several lines of evidence indicate that
Spc72 is abonafideCdc5substrate.Cdc5phosphorylated
Spc72 in vitro,Cdc5activitywas required for thephosphor-
ylation shift of Spc72 in vivo, and the Cdc5 PBD bound
Spc72 in a cellular extract. Further, binding of Spc72 to
the Cdc5 PBD was dependent on phosphoselectivity
elements, cell-cycle stage, and a binding site at S231/
S232 in Spc72. These results are consistent with a model
inwhichakinaseprimesSpc72 forbindingandsubsequent
phosphorylation by Cdc5. The unidentified kinase would
likely localize to the SPB and be active in mitosis but not
G1, and the sequence surrounding S232 indicates phos-
phorylation by a proline-directed kinase, such as cyclin-
dependent kinases or mitogen-activated protein kinases.
Themultitude of potential Cdc5 phosphorylation sites in
Spc72 (Figure 4D) and low endogenous levels of these
proteins, coupled with residual binding to Spc72(S231A,
S232A), presented a technical challenge to studying the
downstream effect of Cdc5 regulation of Spc72. Cell-cy-
cle-regulated Spc72 phosphorylation has been implicated
in shuttling of the g-tubulin complex between distinct
substructures of the SPB, and it is tempting to speculate
that Cdc5 is the kinase responsible [32, 49]. If so, Cdc5 in-
hibition will provide a system to further study this event.
Additionally, regulation of Spc72 binding to microtubule
regulators would be consistent with the Cdc5 inhibition
phenotype. The microtubule motor, Kar9, is asymmetri-
cally recruited to a single SPB prior to anaphase, and sym-
metric Kar9 SPB localization results in a similar phenotype
to Cdc5(L158G) inhibition [50]. Although Kar9 is not knownChemistry & Biology 14, 1261–12to bind Spc72, we observed weak binding of Bim1 and
Clb4, reported determinants of Kar9 localization, to the
Cdc5 PBD (Table S2). Additionally, Stu2, a regulator of
microtubule dynamics binds Spc72 [17, 51] and the Cdc5
PBD (Table S2), as well as Kar9 [52], and is genetically
placed into the Kar9 preanaphase spindle orientation
pathway [53]. Conditional depletion of Stu2 results in fewer
and less dynamic cytoplasmic microtubules, yielding a
misaligned preanaphase spindle [53]. When regions of
Spc72 that bind Stu2 are deleted, cytoplasmic microtu-
bules are reduced in number and have altered dynamics,
with excessively long and stabilized cytoplasmic microtu-
bules observed in anaphase [51]. In G1 they appear nor-
mal, but often detach from the SPB prior to anaphase.
We observed detached cytoplasmic microtubules in a
small number of cdc5-as1 cells treated with CMK, but not
in CMK-treated wild-type cells. Additionally, we found the
Cdc5 PBD to interact with several SPB components, indi-
cating the potential for modulation of Cdc5 function at the
SPB by a number of redundant mechanisms.
We also identified Ulp2 and Mih1 as novel Cdc5 sub-
strates, and both are involved in Cdc5-related functions.
Mih1 is the yeast homolog of Cdc25, which is phosphory-
lated by Plks during mitotic entry [2]. Ulp2 is a desumoy-
lase with roles in centromeric cohesion and recovery
from checkpoint arrest [54, 55]. Advantageously, many
kinetochore proteins were incorrectly annotated as SPB-
localized and included in the PBD binding screen. Of
these, Cse4 and Tid1 bound the PBD, potentially reflect-
ing a role for Cdc5 at the yeast kinetochore, consistent
with other Plks [1]. At the SPB, we find the PBD binds to
Spc110, the nuclear equivalent of Spc72 [56], and there-
fore Cdc5 may also regulate nuclear microtubule dynam-
ics. Likewise, Plk1 spindle functions include centrosome
maturation by phosphorylation of Nlp, which (like Spc72
and Spc110) nucleates microtubules by binding to the
g-tubulin ring complex [1].
The lowabundance and importance ofCdc5 localization
for substrate specificity demanded assays that preserved
cellular context and endogenous expression levels. Con-
sequentially, like Cdc5 itself, many of its interactors identi-
fied here, including Spc72, are present at less than 1,500
molecules per cell. Furthermore, the in vivo method for
identifying kinase-dependent phosphoproteins can po-
tentially be extended to additional kinases functioning in
this pathway or in other dynamic cell processes.
SIGNIFICANCE
Selective small-molecule inhibition of protein kinases
is a powerful tool for studying the biological context in
which they function. This work presents a novel chem-
ical-genetic approach to protein kinase inhibition, ap-
plied to the Polo-like kinase Cdc5, thereby expanding(E) Mutation of consensus Cdc5 binding residues in Spc72 reduces binding to the PBD. PBD binding to Spc72 or Spc72(S231A,S232A) as in (B).
(F) SPB proteins efficiently bound to the Cdc5 PBD. Anti-TAP western blot indicates tagged SPB proteins present in the input mitotic cell extract (5%,
I) or pulled down (P) with GST-PBD. Selected SPB proteins efficiently detected in the pull-down are shown, along with functional information and
protein abundance [7].72, November 2007 ª2007 Elsevier Ltd All rights reserved 1269
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ical regulation.Wedemonstrate the value of the chem-
ical-genetic approach for studying Cdc5 function on
both the phenotypic and molecular level, revealing a
previously unappreciated function for Cdc5 in spindle
positioning and identifying the cellular Cdc5 target,
Spc72. Contrasting with Polo-like kinases in other or-
ganisms, it is not likely that Cdc5 is required for bipolar
spindle formation in yeast. However, these results
provide an indication that Cdc5 may indeed regulate
microtubule function, an avenue for further study. As
far as we know, this study presents a stringent, in vivo
screen for Polo-like kinase substrates and highlights
the utility of chemical genetics for studying rapid sig-
nal transduction events in vivo. The importance of
designing substrate screens in which low abundance
proteins are evaluated is underscored by the identifi-
cation of a low abundance substrate, Spc72. Together,
these results not only illuminate budding yeast Polo-
like kinase function, but also form a template for ki-
nase substrate identification.
EXPERIMENTAL PROCEDURES
Plasmids, Strains, and Yeast Methods
A CDC5 (YMR001C) genomic fragment in pRS315 (p315-CDC5) and
pRS306 (p306-CDC5) were gifts of J. Charles. The L158G mutation
was introduced into p315-CDC5 and p306-CDC5, generating p315-
cdc5-as1 and p306-cdc5-as1. The PBD from p315-CDC5 was cloned
into pGEX-3X (GE Healthcare) to produce pGST-PBD, and
W517F,H641A,K643M mutations were introduced to make pGST-
PBD*. The PBD mutations were cloned into p315-CDC5 from pGST-
PBD*. CDC5 was cloned into pFastBacHT-A (Invitrogen) to produce
pFastBac-CDC5. SPC72 (YAL047C) was amplified from W303 geno-
mic DNA and recombined with a URA3-marked 2 mm plasmid bearing
the GAL1 promoter and TAP tag (kind gift of E.K. O’Shea, Harvard
University) to produce pSPC72. The S231A,S232A mutations were in-
troduced into pSPC72 to produce pSPC72-AA. Mutations were intro-
duced by QuikChange site-directed mutagenesis (Stratagene). Open
reading frames were fully sequenced after amplification. SPC72 plas-
mids encoded an I302N difference from published sequence, which
was confirmed in a W303 strain.
Standard yeast media and genetic techniques were used [57], ex-
cept as specifically described. Strains wereMATa and W303 (Figures
1 and 2 and Figure S1) or S288C (isogenic with EY1274, all other fig-
ures) strain background. cdc5-as1 was introduced at the CDC5 locus
by two-step gene replacement, except as follows. A MATa strain de-
rived from EY1274 carrying a can1D::MFA1p-LEU2 selectable marker
(kind gift of E.K. O’Shea, Harvard University) was transformed with
a marker fusion PCR product generated by amplification of cdc5-as1
and K. lactis URA3 genes. The entire cdc5-as1 gene was sequenced
in the resultant integrated strain, which was then crossed to selected
MATa HIS3 marked TAP-tagged library strains [7] (Open Biosystems)
with a manual 96-pinning tool (V&P Scientific). After sporulation,
TAP-taggedMATa haploids were selected on synthetic media lacking
histidine, arginine, leucine, and uracil and containing 50 mg/ml canava-
nine (Sigma).
Cell-cycle synchronization was obtained by G1 arrest with alpha
factor for 3 hr, followed by washing to release (0 min time point). Alpha
factor was readded at 70–80 min when arresting in the following G1.
Cell-cycle time courses were at 25C except for in Figure 3F, which
was at 30C. Alpha factor was used at 1 mg/ml for bar cells (Figure 2)
and 20 mg/ml for bar+ cells (all other experiments). Mitotic arrests were
obtained by nocodazole treatment at 15 mg/ml for 3 hr.1270 Chemistry & Biology 14, 1261–1272, November 2007 ª20Protein Expression and Purification
6xHis-Cdc5 was prepared as follows. Bacmid was produced from
pFastBac-CDC5 and transfected into Sf9 insect cells by the Bac-to-
Bac Baculovirus expression system (Invitrogen). Sf9 cells were har-
vested after a 2 day infection with Pass 3 baculovirus at 2 3 106
cells/ml, and cell extract prepared by douncing in Cdc5 lysis buffer
(CLB: 25 mM HEPES [pH 7.4], 300 mM NaCl, 10% glycerol, 50 mM
NaF, 50 mM beta-glycerophosphate, 35 nM okadaic acid) with prote-
ase inhibitors (1 mM PMSF, 1 mg/ml leupeptin, 1 mg/ml aprotinin,
1 mg/ml pepstatin). The cleared extract was applied to a HiTrap Chelat-
ing HP column (Amersham) chelated with CoCl2. After washing, peak
6xHis-Cdc5 containing fractions eluted with CLB containing an imid-
azole gradient were combined.
GST-PBD and GST-PBD* were expressed from pGST-PBD and
pGST-PBD* in BL21-CodonPlus(DE3)-RIL cells (Stratagene). Cleared
extracts prepared in GST lysis buffer (GLB: 50 mM Tris [pH 8.0], 1 M
NaCl, 1% NP40, 1 mM PMSF, 1 mg/ml aprotinin, 10 nM DTT) were
loaded onto a glutathione agarose (Sigma) column. After washing,
GST fusion proteins were eluted in 50 mM Tris (pH 8.0), 250 mM
KCl, 5 mM reduced glutathione. Glutathione was subsequently re-
moved with a PD-10 desalting column (GE Healthcare).
Kinase Assays
For Cdc5 kinase assays, Spc72-TAP was isolated from cell extract by
pull-down with IgG sepharose (GE Healthcare) or rabbit IgG (Sigma)
coupled to M-270 epoxy dynabeads (Dynal) and incubated in kinase
buffer (25 mM HEPES [pH 8.0], 60 mM KCl, 15 mM MnCl2, 100 mg/ml
BSA, 80 nMmicrocystin, 1 mM DTT, 100 mM 200 mCi/ml [g-32P]ATP) in
the absence or presence of 100 ng purified baculovirus expressed
6xHis-Cdc5. 32P incorporation was visualized on a Typhoon Phos-
phorImager (GE Healthcare), and images were processed with Image-
Quant software (GE Healthcare).
Western Blotting and Pull-Downs
Blots were probed with anti-TAP (Open Biosystems), anti-Clb2 (kind
gift D. Kellogg), and anti-HA (16B12, Covance) primary antibodies
and anti-rabbit (Amersham) and anti-mouse (Pierce) HRP-conjugated
secondary antibodies. Total protein was stained by using Ponceau S
(Sigma). For phosphorylation gel shifts, cell extracts were prepared
in urea lysis buffer as described [30], and 5 mg was loaded on 5%,
7.5%, or 10% Criterion gels (Biorad) for western blotting.
For PBD binding assays, extracts from TAP-tagged library strains
were prepared in TAP lysis buffer (TLB: 20 mM HEPES [pH 8.0],
150 mM NaCl, 2 mM EDTA, 0.2% NP40, 50 mM NaF, 50 mM beta-
glycerophosphate, 100 mM Na3VO4, 20 nM microcystin, Complete
EDTA-free protease inhibitors [Roche], 1 mg/ml pepstatin) with 1 mM
DTT. Cleared extracts were incubated with purified recombinant
GST-PBD or GST-PBD* and glutathione agarose (Sigma) in TLB with
10 mM DTT for 1 hr at 4. Bead bound complexes were washed and
analyzed by western blot for presence of the TAP-tagged protein.
For Figure 4E, TAP-tagged Spc72 and Spc72(S231A,S232A) were
expressed from pSPC72 and pSPC72-AA in an untagged strain. Ex-
pression was induced for 1 hr in mitotically arrested cells with 2%
galactose, resulting in tagged protein levels lower than that of endog-
enously tagged Spc72 (data not shown).
Microscopy and Image Processing
Cells were fixed with 3.7% formaldehyde overnight at 4. DNA was
stained with 1 mg/ml DAPI. Tubulin was stained with YOL 1/34 (Abcam)
and Cy3-conjugated anti-Rat secondary (Jackson ImmunoResearch).
Images were acquired at 633magnification on a Zeiss Axiovert 200 M
microscope with Axiovision software. Images were cropped, and min-
imum and maximum pixel values adjusted in Photoshop.
Bioinformatic and Statistical Analysis
Candidate Cdc5 substrates were initially selected based on informa-
tion available in September 2003 as follows. First, proteins involved
in Cdc5-dependent processes were identified by Gene Ontology07 Elsevier Ltd All rights reserved
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Polo-like Kinase Targets Spc72 in Mitosis(GO) term searches and selected if they contained a minimal phos-
phorylation or PBD motif. Second, yeast proteins in SWIS-PROT
were evaluated with the Scansite algorithm, which assigns final scores
(Sf) reflecting how well the query sequence matches a position-spe-
cific scoringmatrix representing the optimal Cdc5 PBD or kinasemotif,
normalized to all proteins in the database [25, 26]. These range from
0 (perfect match) to 1 (complete lack of even a minimal binding or
phosphorylation motif). The Cdc5 substrate likelihood score was de-
fined as 1  (0.5 [SfPBD + SfKin]), where SfPBD and SfKin were the final
Scansite scores for the individual PBD and kinase motifs, respectively.
Highest scoring proteins were selected, and the remaining proteins
considered in turn by score, selecting those with cell-cycle function
and nuclear or cytoplasmic localization. Table S1 contains updated
scoring and functional information from October 2006.
Annotations used for identifying SPB-localized proteins are from
SGD (Saccharomyces Genome Database, http://www.yeastgenome.
org, July 2005). Curve fitting, regression analysis, and statistical tests
were performed with Prism 4 (GraphPad software).
Supplemental Data
Supplemental Data include further characterization of Cdc5 inhibi-
tion by CMK, as well as the full set of results from the screens for
Cdc5 substrates and SPB proteins which bind to the Cdc5 PBD, and
are available at http://www.chembiol.com/cgi/content/full/14/11/
1261/DC1/.
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